UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia

Journal of leukocyte biology, 2013-09, Vol.94 (3), p.423-429

2013

Volltextzugriff (PDF)

Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells

The Journal of biological chemistry, 2003-05, Vol.278 (21), p.19245-19256

2003

Volltextzugriff (PDF)

YAP1 Promotes Tumor Invasion and Metastasis in Nasopharyngeal Carcinoma with Hepatitis B Virus Infection

OncoTargets and therapy, 2020-01, Vol.13, p.5629-5642

2020

Volltextzugriff (PDF)

Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma

PloS one, 2013-01, Vol.8 (1), p.e54565

2013

Volltextzugriff (PDF)

Trastuzumab: updated mechanisms of action and resistance in breast cancer

Frontiers in oncology, 2012, Vol.2, p.62-62

2012

Volltextzugriff (PDF)

Mutual regulation of microRNAs and DNA methylation in human cancers

Epigenetics, 2017-03, Vol.12 (3), p.187-197

2017

Volltextzugriff (PDF)

AP-1 Transcription Factors as Regulators of Immune Responses in Cancer

Cancers, 2019-07, Vol.11 (7), p.1037

2019

Volltextzugriff (PDF)

Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (4), p.1273-1278

2013

Volltextzugriff (PDF)

Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival

PloS one, 2020-04, Vol.15 (4), p.e0231003-e0231003

2020

Volltextzugriff (PDF)

Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention

Blood reviews, 2013-11, Vol.27 (6), p.261-267

2013

Volltextzugriff (PDF)

Targeting Jab1/CSN5 in nasopharyngeal carcinoma

Cancer letters, 2012-12, Vol.326 (2), p.155-160

2012

Volltextzugriff (PDF)

Correction: Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma

PloS one, 2020-08, Vol.15 (8), p.e0237943-e0237943

2020

Volltextzugriff (PDF)

hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis

Oncology reports, 2018-11, Vol.40 (5), p.2536-2546

2018

Volltextzugriff (PDF)

Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer

Frontiers in pharmacology, 2018-02, Vol.9, p.135-135

2018

Volltextzugriff (PDF)

JAB1/CSN5: a new player in cell cycle control and cancer

Cell division, 2010-10, Vol.5 (1), p.26-26

2010

Volltextzugriff (PDF)

Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

Journal of experimental & clinical cancer research, 2021-11, Vol.40 (1), p.374-374, Article 374

2021

Volltextzugriff (PDF)

Clinical implications of hepatitis B viral infection in Epstein–Barr virus-associated nasopharyngeal carcinoma

Journal of clinical virology, 2015-03, Vol.64, p.64-71

2015

Volltextzugriff (PDF)

Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma

Oncology reports, 2015-03, Vol.33 (3), p.1418-1426

2015

Volltextzugriff (PDF)

Potential role of jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (17), p.8581-8589

2006

Volltextzugriff (PDF)

Phosphatases: The New Brakes for Cancer Development?

Enzyme Research, 2012, Vol.2012, p.659649-11

2012

Volltextzugriff (PDF)

Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

Journal of experimental & clinical cancer research, 2021-12, Vol.40 (1), p.396-396, Article 396

2021

Volltextzugriff (PDF)

Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair

Advanced science, 2023-01, Vol.10 (3), p.e2205529-n/a

2023

Volltextzugriff (PDF)

Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma

Advanced science, 2024-08, Vol.11 (30), p.e2307747-n/a

2024

Volltextzugriff (PDF)

Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair

Signal transduction and targeted therapy, 2023-03, Vol.8 (1), p.119-119, Article 119

2023

Volltextzugriff (PDF)

Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells

Breast cancer research : BCR, 2011-06, Vol.13 (3), p.R65-R65, Article R65

2011

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(83)
Buchkapitel
(1)

Sprache

Englisch
(84)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia

Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells

YAP1 Promotes Tumor Invasion and Metastasis in Nasopharyngeal Carcinoma with Hepatitis B Virus Infection

Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma

Trastuzumab: updated mechanisms of action and resistance in breast cancer

Mutual regulation of microRNAs and DNA methylation in human cancers

AP-1 Transcription Factors as Regulators of Immune Responses in Cancer

Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1

Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival

Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention

Targeting Jab1/CSN5 in nasopharyngeal carcinoma

Correction: Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma

hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis

Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer

JAB1/CSN5: a new player in cell cycle control and cancer

Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

Clinical implications of hepatitis B viral infection in Epstein–Barr virus-associated nasopharyngeal carcinoma

Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma

Potential role of jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma

Phosphatases: The New Brakes for Cancer Development?

Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair

Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma

Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair

Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells

Suchergebnisse filtern